Increasing Collaborations...

...throughout Regions 1 and 2

Advancing Research...

Join a Biospecimens Workgroup

Together we can minimize cancer health disparities...

...and improve the health of those we serve.

Promoting mentorship...

...supporting future investigators.

Using technology... advance research integration.

Connecting trainees and mentors ... promote mentored career development.

From high school investigators to junior investigators...

...committed to expanding training opportunities in cancer and cancer health disparities research.

Wednesday, May 13, 2015

Cancer Prevention Fellowship Program Now Accepting Applications

National Cancer Institute is now accepting applications for the Cancer Prevention Fellowship Program (CPFP). The deadline is August 25, 2015. Applicants should posses an M.D., Ph.D., J.D., or other doctoral degree in a related discipline or must be enrolled in an accredited doctoral degree program and fulfull all degree requirements by June 2016. Additionally, applicants must be a citizen or permanent resident of the U.S. and have no more than five years relevant postdoctoral experience.

To learn more about application information and program details, visit or click here for the Cancer Prevention Fellowship Program Catalog.

Tuesday, May 5, 2015

Upcoming Webinar: Promoting Yourself and Your Research and the New NIH Biosketch

Dr. Beti Thompson, the GMaP Region 6 PI, will be a featured speaker on an American Society of Preventive Oncology (ASPO) webinar this coming Friday. She will be discussing the new NIH biosketch and how faculty/early stage investigators can successfully promote their research.

Friday, May 8 at 9am Pacific/11am Central/12pm Eastern

Panelists: Beti Thompson, PhD, Fred Hutchinson Cancer Center and Elizabeth Travis, PhD, MD Anderson Cancer Center
Moderator: Cheryl Thompson, PhD, Case Western Reserve University

To join webinar please click here (you may join up to 30 minutes early):

Tuesday, April 21, 2015

ASPO webinar: New NIH Biosketch

Promoting yourself and your research and the new NIH Biosketch

Please join us: Friday, May 8 at 9:00am Pacific/11:00am Central/12:00pm Eastern

Panelists: Elizabeth Travis, PhD, MD Anderson Cancer Center Beti Thompson, PhD, Fred Hutchinson Cancer Center

Moderator: Cheryl Thompson, PhD, Case Western Reserve University

To join webinar please click here

Thursday, March 26, 2015

Global Cancer Project Map

The Center for Global Health is pleased to announce the launch of the Global Cancer Project Map, developed by NCI, Center for Global Health and Global Oncology, Inc. Click here: Global Cancer Project Map to read more about this collaborative effort on the CGH Spotlight Blog: Mapping International Cancer Activities - Global Cancer Project Map Launch

New Highlights from NIH

New Funding Update: FY 2015 Funding OpportunityAnnouncements from Office of Minority Health

New Event Update: Invitation to AACR Focus Groups to help AACR understand researchers’ preferences for how scientific journal content is presented online.

New Event Update: Ken Burns’ 3-part film series “Cancer: The Emperor of All Maladies” airs March 30 at 9pm ET.

Tuesday, March 17, 2015

March is Colorectal Cancer Awareness Month! Participate in the next Research to Reality cyber-seminar

March is Colorectal Cancer Awareness Month! 

Participate in the next Research to Reality cyber-seminar for information on how to increase colorectal cancer screening rates in underserved populations. Click link below for more information and how to register for the cyber-seminar!

Increasing CRC Screening Rates across Underserved Populations: Strategies, Collaborations and Opportunities

Tuesday, February 17, 2015

R2R: Tools of the Trade Putting Public Health Evidence in Action

Tools of the Trade: Putting Public Health Evidence in Action
Tuesday, February 24, 2015, 2:00 p.m. – 3:00 p.m. ET

This year, we celebrate the 5th Anniversary of the NCI Research to Reality community of practice. R2R was developed to engage researchers and practitioners in an ongoing discussion around moving cancer control research into practice.  R2R will only be partially successful if we fail to build capacity for others to join this essential conversation. We are delighted therefore that our February cyber-seminar will introduce a newly released curriculum designed to train community program planners and health educators to locate, select, adapt and implement evidence-based strategies into practice. 

Putting Public Health Evidence in Action is Health is an interactive seven-module training curriculum developed by the Cancer Prevention and Control Research Network (CPCRN).  CPCRN is a network of eight centers that receive funding from the Centers for Disease Control and Prevention and the National Cancer Institute.  The training curriculum is intended for public health practitioners, state and local health department staff, health educators, healthcare providers, community advocates, academic/research faculty and staff, faith-based leaders, and other members of community-based organizations. 

Drs. Jennifer Leeman and Cam Escoffery will introduce the curriculum and how you might adapt and use it to train your staff, students, and community partners.  Following their presentations, we will host a robust, interactive discussion with you about your experiences building the capacity of others to move evidence-based programs and policies into practice. 


Jennifer Leeman, DrPH, MDIV
Assistant Professor, UNC School of Nursing
University of North Carolina at Chapel Hill
CPCRN Position: Principal Investigator

Cam Escoffery, PhD, MPH, CHES
Assistant Professor, Emory University
Rollins School of Public Health
CPCRN Position: Co-Investigator

Please click on the following link for more information and to register for this event:

Following registration, you will receive a confirmation email with the toll free number, web URL,and participant passcode.  This cyber-seminar will be archived on the Research to Reality (R2R) web site at approximately one week following the presentation.

If you have missed any of the previous cyber-seminars, you can view them all on the R2R Archive.  Watch the presentations, and join in the discussions.   

For more information on the cyber-seminar series please email

Tuesday, February 3, 2015

Dr. Hébert: MIR ratio possible global disparities indicator in #cancer screening/treatment . #ArnoldSchool @CPCPUSC

Hébert and co-author determine mortality-to-incidence ratio may serve as indicator for global disparities in colorectal cancer screening and treatment

January 29, 2015
James Hébert
James Hébert
James Hébert, Health Sciences Distinguished Professor in the Department of Epidemiology and Biostatistics at the Arnold School of Public Health, and Vasu Sunkara (Harvard University) have determined that the mortality-to-incidence ratio (MIR) can be used to identify disparities in deaths due to colorectal cancer that reflect differences in screening and treatment globally. The MIR is a measure popularized by Hébert and colleagues in USC’s Cancer Prevention and Control Program that compares cancer mortality in relation to incidence. In other words, scientists use MIRs to take into account incidence and mortality to examine differences in survival rates for various types of cancer.
In their study, published in the journal Cancer, the authors examined the relationship between colorectal cancer MIRs and health system rankings, which included factors such as health care financing, responsiveness to health needs and availability of screening facilities, for all 34 Organisation for Economic Cooperation and Development (OECD) countries. The researchers found that countries with lower-than-expected MIRs (i.e., fewer deaths than expected based on their incidence rate) are more likely to have higher health system rankings. Accordingly, these countries also are more likely to have formal colorectal cancer screening programs in place and a larger percentage of the population participating in the screenings. Conversely, countries with higher-than-expected MIRs, where mortality rates exceed expectations based on incidence, had lower health system rankings and were less likely to have strong screening programs and high participation rates. These correlations suggest that the MIR has potential as an indicator of the long-term success of global cancer surveillance programs.
“The MIR appears to be a promising method to help identify global populations at risk for cancers that can be screened and effectively treated,” says Sunkara. “In this capacity, it is potentially a useful tool for monitoring an important cancer outcome to inform and improve health policy at a national and international level.”
Hébert, who also serves as director of the Cancer Prevention and Control Program at the Arnold School, has used the MIR previously at the state (i.e., in both South Carolina and Georgia) and national level within the U.S. “The use of the MIR internationally opens new possibilities for testing the relationship between this important indicator of cancer outcome and characteristics of countries’ health care delivery systems,” he adds.
The study’s evidence-based confirmation that the MIR can be used in this manner is timely given that inequalities in cancer screening, incidence, treatment and survival continue to worsen globally. The authors suggest that countries with high MIR values should consider using MIR-based analyses to help drive health care financing and policy reform to increase access to high-quality colorectal screening programs and enhance health system infrastructure and performance overall. Because colorectal cancer is one of the most preventable forms of cancer and yet one of the most expensive to treat, shifting to this type of approach will be both cost-effective and life-saving.

Thursday, December 4, 2014

New NIH and External Opportunities

December 4, 2014

Find a variety of new job opportunities, funding/training opportunities, resources/tools, and upcoming events by clicking here!

Health Communications post-doc position at Washington University in St. Louis

December 4, 2014

Health communication and behavior emphasis Washington University School of Medicine and the Siteman Cancer Center, a National Cancer Institute-designated Comprehensive Cancer Center, are seeking applications for postdoctoral fellowships in Cancer Prevention and Control with a special emphasis in health communication and behavior.

PhD, DrPH, MD, or other doctoral degree in a public health related discipline, or a doctoral degree in another discipline (e.g., psychology, communication) with interest in transitioning to public health research. 

For more information, click here